These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vaccination with purified microgamete antigens prevents transmission of rodent malaria. Harte PG; Rogers N; Targett GA Nature; 1985 Jul 18-24; 316(6025):258-9. PubMed ID: 4022122 [TBL] [Abstract][Full Text] [Related]
3. Vaccination to prevent transmission of Plasmodium yoelii malaria. Mendis KN; Targett GA Parasite Immunol; 1982 Mar; 4(2):117-27. PubMed ID: 7070834 [TBL] [Abstract][Full Text] [Related]
4. The Plasmodium yoelii microgamete surface antigen (PyMiGS) induces anti-malarial transmission blocking immunity that reduces microgamete motility/release from activated male gametocytes. Tachibana M; Ishino T; Tsuboi T; Torii M Vaccine; 2018 Nov; 36(49):7463-7471. PubMed ID: 30420038 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria. Peiris JS; Premawansa S; Ranawaka MB; Udagama PV; Munasinghe YD; Nanayakkara MV; Gamage CP; Carter R; David PH; Mendis KN Am J Trop Med Hyg; 1988 Jul; 39(1):26-32. PubMed ID: 3041855 [TBL] [Abstract][Full Text] [Related]
6. Anti-gamete monoclonal antibodies synergistically block transmission of malaria by preventing fertilization in the mosquito. Rener J; Carter R; Rosenberg Y; Miller LH Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6797-9. PubMed ID: 6935685 [TBL] [Abstract][Full Text] [Related]
7. Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum. Rener J; Graves PM; Carter R; Williams JL; Burkot TR J Exp Med; 1983 Sep; 158(3):976-81. PubMed ID: 6350527 [TBL] [Abstract][Full Text] [Related]
8. Current studies related to the development of transmission-blocking malaria vaccines: a review. Meuwissen JH Trans R Soc Trop Med Hyg; 1989; 83 Suppl():57-60. PubMed ID: 2576163 [TBL] [Abstract][Full Text] [Related]
9. An antibody against an Anopheles albimanus midgut myosin reduces Plasmodium berghei oocyst development. Lecona-Valera AN; Tao D; Rodríguez MH; López T; Dinglasan RR; Rodríguez MC Parasit Vectors; 2016 May; 9(1):274. PubMed ID: 27165123 [TBL] [Abstract][Full Text] [Related]
10. Waiting for the vaccine: sporozoite vaccine research entails important progress in malaria epidemiology. Esposito F; Gambella R; Modiano D; Lamizana L; Lombardi S; Rotigliano G; Habluetzel A Parassitologia; 1991 Apr; 33(1):85-91. PubMed ID: 1841198 [TBL] [Abstract][Full Text] [Related]
11. Plasmodium cynomolgi: serum-mediated blocking and enhancement of infectivity to mosquitoes during infections in the natural host, Macaca sinica. Naotunne TD; Rathnayake KD; Jayasinghe A; Carter R; Mendis KN Exp Parasitol; 1990 Oct; 71(3):305-13. PubMed ID: 2209788 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility of species A, B, and C of Anopheles culicifacies complex to Plasmodium yoelii yoelii and Plasmodium vinckei petteri infections. Kaur S; Singh OP; Adak T J Parasitol; 2000 Dec; 86(6):1345-8. PubMed ID: 11191914 [TBL] [Abstract][Full Text] [Related]
13. Plasmodium yoelii: characterization of a protective idiotype during malarial infection in mice. Majarian WR; Daly TM; Burns JM; Long CA Exp Parasitol; 1988 Dec; 67(2):227-37. PubMed ID: 2461316 [TBL] [Abstract][Full Text] [Related]
14. Plasmodium yoelii: comparison of indirect immunofluorescence and radioimmunoassay for detecting monoclonal antibodies to malaria. Taylor DW; Munoz PA; Kim KJ; Evans CB; Asofsky R Exp Parasitol; 1982 Jun; 53(3):362-70. PubMed ID: 6177548 [No Abstract] [Full Text] [Related]
15. Effects of transmission-blocking vaccines simultaneously targeting pre- and post-fertilization antigens in the rodent malaria parasite Plasmodium yoelii. Zheng L; Pang W; Qi Z; Luo E; Cui L; Cao Y Parasit Vectors; 2016 Aug; 9(1):433. PubMed ID: 27502144 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes. Kaushal DC; Carter R; Rener J; Grotendorst CA; Miller LH; Howard RJ J Immunol; 1983 Nov; 131(5):2557-62. PubMed ID: 6631012 [TBL] [Abstract][Full Text] [Related]
17. Target antigens in malaria transmission blocking immunity. Carter R; Miller LH; Rener J; Kaushal DC; Kumar N; Graves PM; Grotendorst CA; Gwadz RW; French C; Wirth D Philos Trans R Soc Lond B Biol Sci; 1984 Nov; 307(1131):201-13. PubMed ID: 6151684 [TBL] [Abstract][Full Text] [Related]
18. Plasmodium berghei: serum-mediated inhibition of infectivity of infected mice to Anopheles stephensi mosquitoes. Fleck SL; Butcher GA; Sinden RE Exp Parasitol; 1994 Feb; 78(1):20-7. PubMed ID: 8299757 [TBL] [Abstract][Full Text] [Related]
19. Anopheles gambiae salivary gland proteins as putative targets for blocking transmission of malaria parasites. Brennan JD; Kent M; Dhar R; Fujioka H; Kumar N Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13859-64. PubMed ID: 11087838 [TBL] [Abstract][Full Text] [Related]
20. Factors regulating natural transmission of Plasmodium berghei to the mosquito vector, and the cloning of a transmission-blocking immunogen. Sinden RE; Barker GC; Paton MJ; Fleck SL; Butcher GA; Waters A; Janse CJ; Rodriguez MH Parassitologia; 1993 Jul; 35 Suppl():107-12. PubMed ID: 7694225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]